InsidersTradesSigma
Total declarations
Companies
▲ Purchases (3 ops.)
▼ Sales (7 ops.)
Insider track record
Board DirectorDisclosed buys
3
Disclosed sells
7
T+90 hit rate
43%
T+90 mean return
-20.2%
Across 7 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Explore the detailed record of transactions filed by Freitag Gregory Gene, Director. Director active across 2 companies, notably Axogen, Inc.. Cumulatively, 20 reports have been logged. Breakdown: 3 buys · 7 sells. Total volume traded: €1.1m. Activity tracked since 26 May 2021. The latest transaction was disclosed on 28 February 2025 (Acquisition). Regulator: SEC (Form 4). All data is openly available.
Declarations20 total
15,060 shares@ US$1.6622.6% of flowCommon StockSEC:0001140361-25-006784:0
Ideal exit: 25 Nov 2025 (T+270)
11,904 shares0Common StockSEC:0000805928-24-000075:0
25,000 shares@ US$9.009.8% of flowCommon StockSEC:0000805928-24-000039:0
12,500 shares@ US$8.654.7% of flowCommon StockSEC:0000805928-23-000062:0
2,828 shares@ US$9.171.1% of flowCommon StockSEC:0000805928-23-000056:0
13,000 shares@ US$12.747.6% of flowCommon StockSEC:0000805928-22-000121:0
13,000 shares@ US$12.507.7% of flowCommon StockSEC:0000805928-22-000119:0
8,886 shares@ US$9.6964.0% of flowCommon StockSEC:0000805928-22-000107:0
24,000 shares@ US$10.6411.8% of flowCommon StockSEC:0000805928-22-000105:0
83,000 shares@ US$3.3813.0% of flowCommon StockSEC:0000805928-22-000098:0
30,296 shares@ US$9.2613.0% of flowCommon StockSEC:0000805928-22-000098:1
3,036 shares0Common StockSEC:0000805928-22-000062:0
9,250 shares@ US$19.177.0% of flowCommon StockSEC:0000805928-21-000121
9,250 shares@ US$19.170.0096% mcap25.6% of flowCommon StockSEC:0000805928-21-000121:0
5,882 shares@ US$8.5038.7% of flowCommon StockSEC:0001140361-21-021489
Ideal exit: 12 Mar 2022 (T+270)
5,882 shares@ US$8.500.098% mcap50.0% of flowCommon StockSEC:0001140361-21-021489:0
Ideal exit: 12 Mar 2022 (T+270)
24,000 shares@ US$3.670.0047% mcap12.5% of flowCommon StockSEC:0000805928-21-000118:0
24,000 shares@ US$3.673.4% of flowCommon StockSEC:0000805928-21-000118
22,954 shares@ US$3.670.0045% mcap11.9% of flowCommon StockSEC:0000805928-21-000099:0
22,954 shares@ US$3.6711.9% of flowCommon StockSEC:0000805928-21-000099
20 of 20 declarations
About Freitag Gregory Gene
Gregory Gene Freitag is a Board Member at Axogen, Inc. and PDS Biotechnology Corp. He plays a key role in the governance of the companies, contributing to strategic decision-making. His experience is valuable in guiding growth and innovation initiatives.
